Persistence Market Research Pvt. Ltd.

Celiac Drugs Market is Expected to Witness a Steady Growth by 2021

Press Release   •   Feb 03, 2017 01:33 EST

These tests detect auto-antibodies which are present in higher-than-normal levels in the blood of patients who have celiac disease. If the tests show positive results for celiac disease, a small bowel biopsy is done to confirm the diagnosis and determine the level of damage to the lining of the intestine. Approximately, 6 million people suffer from celiac disease in the U.S and Europe. Currently, no drugs, vaccines, or surgical treatments are available for the disease. Gluten free diet is recommended to control the symptoms and prevent long term effects of celiac disease. Immune-modulatory and other therapies are used for the treat the symptoms of celiac disease.

A sample of this report is available upon request @

North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region.

Increase in healthcare expenditure, changing lifestyles, increasing awareness about healthcare, and increasing number of initiatives by various governments and government associations are some of the key factors driving the growth of the global celiac drugs market. However, complex regulatory frameworks for the approval of drugs in most countries is a major restraint on the growth of the global celiac drugs market.

To view TOC of this report is available upon request @

Innovation of drugs to treat celiac disease would help develop opportunities for the global celiac disease market. The major companies operating in the global celiac drugs market are Alvine Pharmaceuticals, Inc., Alba Therapeutics Corporation, ImmusanT, and the Institute for Protein Design.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City, 

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353